ࡱ> 463{`|bjbjFF .,,| 6666J S bL  $ hq RRR   R R  V #r"f6> : $# 0S x     v S RRRR Clin Microbiol Infect. 2002 Jul;8(7):388-96. HYPERLINK "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Display&dopt=pubmed_pubmed&from_uid=12199848" Related Articles,  HYPERLINK "javascript:PopUpMenu2_Set(Menu12199848);" \t "_self" Links  HYPERLINK "http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3046&uid=12199848&db=pubmed&url=http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1198-743X&date=2002&volume=8&issue=7&spage=388"  INCLUDEPICTURE "http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--www.blackwell-synergy.com-images-synergy_linkout.gif" \* MERGEFORMATINET  The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Boyanova L, Mentis A, Gubina M, Rozynek E, Gosciniak G, Kalenic S, Goral V, Kupcinskas L, Kantarceken B, Aydin A, Archimandritis A, Dzierzanowska D, Vcev A, Ivanova K, Marina M, Mitov I, Petrov P, Ozden A, Popova M. Department of Microbiology, Medical University of Sofia, Sofia, Bulgaria. l.boyanova@lycos.com OBJECTIVE: To evaluate the primary, secondary and combined resistance to five antimicrobial agents of 2340 Helicobacter pylori isolates from 19 centers in 10 countries in eastern Europe. METHODS: Data were available for centers in Bulgaria, Croatia, the Czech Republic, Estonia, Greece, Lithuania, Poland, Russia, Slovenia and Turkey. Susceptibility was tested by agar dilution (seven countries), E test (five countries) and disk diffusion (three countries) methods. Resistance breakpoints (mg/L) were: metronidazole 8, clarithromycin 1, amoxicillin 0.5, tetracycline 4, and ciprofloxacin 1 or 4 in most centers. Primary and post-treatment resistance was assessed in 2003 and 337 isolates respectively. Results for 282 children and 201 adults were compared. RESULTS: Primary resistance rates since 1998 were: metronidazole 37.9%, clarithromycin 9.5%, amoxicillin 0.9%, tetracycline 1.9%, ciprofloxacin 3.9%, and both metronidazole and clarithromycin 6.1%. Isolates from centers in Slovenia and Lithuania exhibited low resistance rates. Since 1998, amoxicillin resistance has been detected in the southeastern region. From 1996, metronidazole resistance increased significantly from 30.5% to 36.4%, while clarithromycin resistance increased slightly from 8.9% to 10.6%. In centers in Greece, Poland, and Bulgaria, the mean metronidazole resistance was slightly higher in adults than in children (39% versus 31.2%, P > 0.05); this trend was not found for clarithromycin or amoxicillin (P > 0.20). Post-treatment resistance rates exhibited wide variations. CONCLUSIONS: In eastern Europe, primary H. pylori resistance to metronidazole is considerable, and that to clarithromycin is similar to or slightly higher than that in western Europe. Resistance to amoxicillin, ciprofloxacin and tetracycline was detected in several centers. Primary and post-treatment resistance rates vary greatly between centers. -.     z { | } ~ ܱ܎kU+hhhh5B*CJ\aJmHphsH&j hhhhB*UmHph3sHhhhhB*mHph3sH&jhhhhB*UmHph3sHhhhhCJaJmHsH&jhhhhB*UmHphsH-hhhhB*CJOJQJ^JmHph3fsH&jhhhhB*UmHphsHhhhhB*mHphsH-  {| ^gdhIkd $$If0p#634a $$Ifa$gdh $Ifgdh| {|hhhhhhB*mHphsH#hhhh5B*\mHphsH,1h. A!"#$% Dd,@  c :ANormalFax01C"æ <!-- var PopUpMenu2_LocalConfig_jsmenu3Config = [ ["ShowCloseIcon","yes"], ["Help","window.open('/entrez/query/static/popup.html','Links_Help','resizable=no,scrollbars=yes,toolbar=no,location=no,directories=no,status=no,menubar=no,copyhistory=no,alwaysRaised=no,depend=no,width=400,height=500');"], ["TitleText"," Links "] ] //--> JavaScript1.2b!X󆡑NBD7nX󆡑NBPNG  IHDRfsRGB@}0PLTE{bIDATE!0Eq^uM&VUp\ &C|)"3.8̴(6 jPtsʄ&)NU- \^w& ^eyƾ_c|_^9IENDB` Dd,  c :ANormalFax01C". <!-- var Menu12199848 = [ ["UseLocalConfig","jsmenu3Config","",""], ["Cited in PMC","window.top.location='http://www.pubmedcentral.gov/tocrender.fcgi?action=cited&tool=pubmed&pubmedid=12199848'","",""], ["Books","window.top.location='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&list_uids=12199848&dopt=Books'","",""], ["LinkOut","window.top.location='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&list_uids=12199848&dopt=ExternalLink'","",""] ] //--> JavaScript1.2b!X󆡑NB7nX󆡑NBPNG  IHDRfsRGB@}0PLTE{bIDATE!0Eq^uM&VUp\ &C|)"3.8̴(6 jPtsʄ&)NU- \^w& ^eyƾ_c|_^9IENDB`_$$If!vh55 #v#v :V 6,534  Ddzz  c VA &--wwwClick here to readbDJN3c 7nDJN3PNG  IHDRs##PLTE  $%&('(+.,-122456mnqrvwꆇꙗ   " !!##&&'')))),*++++,,1///00211122333344556688::==@>DBBBEDDCGFIGNMMMUSeehfjjjjmmoosryyyx|{}|醄ꈈ덍암땔ꖔ뙘  #""('''&&0//,++=<<<;;988877544433UTTRQQQPPNMMMLLJIIIHHFEEEDDA@@@??}|||{{yxxxwwutttsssrronnkjjgfffeecbbbaa_^^^]][ZZZYYYXXWVVVUUi6bKGDH cmPPJCmp0712HsPIDATXGyXE@>U;NAkjUV0[`֣}`A(-- J) 晣, BXof6! ʇffͼyv7FQzXXz#_M™30d~C'>|2}y `&J[Mh34!̧a~=iZFFFZ&j [؍17L=5aofgE1FH(TaDa5AfBW=+Cԣ$EZÒז\Zk0S'{}>+>_OPtQ;r7h/K% 3] -?@0 T\%ANG10^JY>YaF ,n,fO3!R׳䵃RMj,S)Pa}Tx' !K fX']!23g2sRsB7\b ]%Y1s,<M&@K1/QPf\V%+'g?\ezb)uZ2?X:|}k*|B-ŧEOK iu҄ ~+")rW,w+ЧvwtN'ԘR_E)ljXݧl.J 6S9P;`T5qgwcw`+g5rGGW9[<2:jۢn-cIœI:[W ₟e#J*؍_vAkGS߮"ye|6аۢCx3TYa\nQEސuqypܭd*Ʈ:uvag*k9@eꎎ[y1y3$CuW`jw|ؑ`(ߵo.{Voku~Ӱqw*on|QFG5;3"eO;MGf.um&W>*lH EYDg9E8hbg019)oީőJIENDB`@@@ NormalCJ_HaJmH sH tHDA@D Default Paragraph FontRi@R  Table Normal4 l4a (k@(No List4U`4 h Hyperlink >*ph3| -{ ~ 0 0 0 00-{ ~ {0Єy0@ 000{  | | | -z|}| XXXCF6^~ b~ C*urn:schemas-microsoft-com:office:smarttagsmetricconverter N4 in ProductID)-8<AESWdhl "#&'.09>FGQUYZghnw  !#)+46<>DFNSY[ijmntuw}"&17CKXhoqx #$)/35BJX_jq}] a b i j q r y ~ { ~ { ~ ~ h-~ @{ { { { | P@UnknownGz Times New Roman5Symbol3& z Arial"1FF  !4w w 2KX)?h2Clin Microbiol InfectSmilja KalenicSmilja KalenicOh+'0 ( H T `lt|Clin Microbiol InfectSmilja KalenicNormalSmilja Kalenic1Microsoft Office Word@@̔O"f@̔O"f ՜.+,D՜.+,@ hp|  MEFw G Clin Microbiol Infect Title 8@ _PID_HLINKSAp~)http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3046&uid=12199848&db=pubmed&url=http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1198-743X&date=2002&volume=8&issue=7&spage=388R \,)javascript:PopUpMenu2_Set(Menu12199848);R ihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Display&dopt=pubmed_pubmed&from_uid=12199848R   !"$%&'()*,-./0125Root Entry F 0r"f7Data 1TableWordDocument.SummaryInformation(#DocumentSummaryInformation8+CompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q